These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1176768)

  • 1. Biologic properties of transplantation immune sera. IV. Influence of the course of immunization, dilution and complexing to antigen on enhancing activity of Ig classes.
    Duc HT; Kinsky RG; Kanellopoulos J; Voisin GA
    J Immunol; 1975 Oct; 115(4):1143-50. PubMed ID: 1176768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune status of mice tolerant of living cells. II. Continuous presence and nature of facilitation-enhancing antibodies in tolerant animals.
    Voisin GA; Kinsky RG; Duc HT
    J Exp Med; 1972 May; 135(5):1185-203. PubMed ID: 4623319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of pure IgG subclasses from mouse alloantiserum and their activity in enhancement and hyperacute rejection of skin allografts.
    Jansen JL; Gerard AP; Kamp J; Tamboer WP; Wijdeveld PG
    J Immunol; 1975 Aug; 115(2):387-91. PubMed ID: 807636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-dependent lymphocyte cytotoxicity in the murine sarcoma virus system: activity of IgM and IgG with specificity for MLV determined antigen(s).
    Lamon EW; Skurzak HM; Andersson B; Whitten HD; Klein E
    J Immunol; 1975 Apr; 114(4):1171-6. PubMed ID: 1117138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between tolerance and facilitation of allografted cells.
    Voisin GA; Kinsky R; Duc HT
    Transplant Proc; 1972 Sep; 4(3):377-82. PubMed ID: 4562765
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphocyte-antibody interactions in immunological enhancement.
    Takasugi M; Hildemann WH
    Transplant Proc; 1969 Mar; 1(1):530-4. PubMed ID: 5406837
    [No Abstract]   [Full Text] [Related]  

  • 7. Ia versus K/D antigens in immunological enhancement of tumour allografts. II. Studies with alloimmune sera prepared in recombinant strains.
    Duc HT; Kinsky RG; Voisin GA
    Ann Immunol (Paris); 1979; 130C(3):461-74. PubMed ID: 475347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice.
    Jose DG; Good RA
    Cancer Res; 1973 Apr; 33(4):807-12. PubMed ID: 4633154
    [No Abstract]   [Full Text] [Related]  

  • 9. Evolution of alloantibodies and suppressor cells in allografted mice treated for passive enhancement.
    Duc HT; Kinsky RG; Monnot P; Voisin GA
    Cell Immunol; 1985 Oct; 95(1):180-94. PubMed ID: 4028170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restricted IgG isotype profiles in T. cruzi infected mice and Chagas' disease patients.
    Scott MT; Goss-Sampson M
    Clin Exp Immunol; 1984 Nov; 58(2):372-9. PubMed ID: 6437715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ehancement and hyperacute rejection of skin grafts in the mousefailure to separate cytotoxic and enhancing antibodies from alloantiserum with physicochemical methods.
    Jansen JL; Koene RA; Kamp GJ; Gerlag PG; Wijdeveld PA
    J Immunol; 1975 May; 114(5):1557-62. PubMed ID: 804518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of the intensification of the immune response to Staphylococcus in mice after the transplantation of primed donor splenocytes].
    Bobrovnik SA; Liashchenko KP
    Biull Eksp Biol Med; 1985 Jul; 100(7):49-51. PubMed ID: 4040404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The serologic response to Meth A sarcoma vaccines after cyclophosphamide treatment is additionally increased by various adjuvants.
    Livingston PO; Jones M; Deleo AB; Oettgen HF; Old LJ
    J Immunol; 1985 Aug; 135(2):1505-9. PubMed ID: 4008930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B lymphocyte regulation of the immune system. I. In vivo biologic activity of the novel lymphokine, B cell-derived enhancing factor (BEF).
    del Guercio P; del Guercio MF; Katz DH
    J Immunol; 1985 Feb; 134(2):996-1002. PubMed ID: 3871223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of anti-mouse-skin-epithelium rabbit-IgG on survival of mouse-skin homografts.
    Fekete B; Szegedi G; Gasztonyi G; Szabó G; Petrányi G
    Acta Med Acad Sci Hung; 1973; 29(3):279-84. PubMed ID: 4201103
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the induction of the humoral immune responses to Bacteroides gingivalis fimbrial antigen in mice].
    Shimauchi H
    Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):60-77. PubMed ID: 1983739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
    McDonald TL
    J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allograft immunity in the mouse. 1. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization.
    MacDonald HR; Phillips RA; Miller RG
    J Immunol; 1973 Aug; 111(2):565-74. PubMed ID: 4123983
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulation of antibody response to SRBC. II. Effect of a non-specific stimulation.
    Ríhová B; Ríha I; Hofman J
    Folia Biol (Praha); 1981; 27(1):15-27. PubMed ID: 7009228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antigenic sites implicated in tumour allograft enhancement].
    Duc HT; Kinsky RG; Voisin GA
    Ann Immunol (Paris); 1977; 128(1-2):19-20. PubMed ID: 322579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.